SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-046617
Filing Date
2022-08-11
Accepted
2022-08-11 08:16:11
Documents
51
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_cormedix.htm   iXBRL 10-Q 902655
2 CERTIFICATION f10q0622ex31-1_cormedixinc.htm EX-31.1 11039
3 CERTIFICATION f10q0622ex31-2_cormedixinc.htm EX-31.2 10966
4 CERTIFICATION f10q0622ex32-1_cormedixinc.htm EX-32.1 3425
5 CERTIFICATION f10q0622ex32-2_cormedixinc.htm EX-32.2 3620
  Complete submission text file 0001213900-22-046617.txt   4606693

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE crmd-20220630.xsd EX-101.SCH 41242
7 XBRL CALCULATION FILE crmd-20220630_cal.xml EX-101.CAL 29770
8 XBRL DEFINITION FILE crmd-20220630_def.xml EX-101.DEF 184230
9 XBRL LABEL FILE crmd-20220630_lab.xml EX-101.LAB 386017
10 XBRL PRESENTATION FILE crmd-20220630_pre.xml EX-101.PRE 193982
45 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_cormedix_htm.xml XML 699789
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34673 | Film No.: 221153809
SIC: 2834 Pharmaceutical Preparations